Articolul precedent |
Articolul urmator |
734 13 |
Ultima descărcare din IBN: 2023-05-28 04:01 |
Căutarea după subiecte similare conform CZU |
547:577:576 (1) |
Chimie organică (475) |
Bazele materiale ale vieții. Biochimie. Biologie moleculară. Biofizică (657) |
Biologie celulară și subcelulară. Citologie (129) |
SM ISO690:2012 MORĂRESCU (CHETRARU), Olga, TRAISTARI, Marionela, BARBA, Alic, DUKA, Gh., UNGUR, Nikon, KULCIŢKI, Veaceslav. Selective synthesis of 13-epi-manoyl oxide. In: New frontiers in natural product chemistry.: A destiny on the altar of research. Dedicated to academician Pavel Vlad, Ed. 6, 21 mai 2021, Chișinău. Chișinău, Republica Moldova: Tipografia "Artpoligraf", 2021, Ediția 6, p. 34. ISBN 978-9975-3336-7-2. DOI: https://doi.org/10.19261/nfnpc.2021.ab27 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
New frontiers in natural product chemistry. Ediția 6, 2021 |
|||||||
Conferința " New frontiers in natural product chemistry." 6, Chișinău, Moldova, 21 mai 2021 | |||||||
|
|||||||
DOI: https://doi.org/10.19261/nfnpc.2021.ab27 | |||||||
CZU: 547:577:576 | |||||||
Pag. 34-34 | |||||||
|
|||||||
Descarcă PDF | |||||||
Rezumat | |||||||
Labdane-type diterpenes are excellent examples of natural products with important pharmaceutical activities. Besides, several labdanes are quite abundant in nature and/or are commercially, such as sclareol 1. Hence, they are useful starting materials for chemical transformations. On the other hand, manoyl oxide 2 and 13-epi-manoyl oxide 3 are labdane compounds with skeleton identical to forskolin – a secondary metabolite isolated from Coleus forskohlii plant and showing a myriad of therapeutic activities [1], and other relevant natural compounds reported in structure-activity relationship (SAR) [2,3]. We have also demonstrated recently a free-radical procedure for structural modification of both forskolin and manoyl oxides [4,5] leading to an unusual distal functionalization of 13-epi- framework. In order to explore the full potential of such late-stage functionalization, one needs reliable sources of 13-epi-manoyl oxide 3, which ideally is made available via selective synthesis. The current work presents the selective one-step synthesis of 13-epi-manoyl oxide 3 basing on a low-temperature superacidic cyclization of sclareol 1 (Scheme 1). An older contribution of some of us reported an equimolar mixture of epimers [6]. Now, the reaction conditions have been finely tuned in order to achieve a 9:1 ratio in favor of the desired 13-epioxide 3. The preparative value of the elaborated procedure was convincingly demonstrated. Scheme 1 |
|||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-131137</cfResPublId> <cfResPublDate>2021</cfResPublDate> <cfVol>Ediția 6</cfVol> <cfStartPage>34</cfStartPage> <cfISBN>978-9975-3336-7-2</cfISBN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/131137</cfURI> <cfTitle cfLangCode='EN' cfTrans='o'>Selective synthesis of 13-epi-manoyl oxide</cfTitle> <cfAbstr cfLangCode='EN' cfTrans='o'><p>Labdane-type diterpenes are excellent examples of natural products with important pharmaceutical activities. Besides, several labdanes are quite abundant in nature and/or are commercially, such as sclareol 1. Hence, they are useful starting materials for chemical transformations. On the other hand, manoyl oxide 2 and 13-epi-manoyl oxide 3 are labdane compounds with skeleton identical to forskolin – a secondary metabolite isolated from Coleus forskohlii plant and showing a myriad of therapeutic activities [1], and other relevant natural compounds reported in structure-activity relationship (SAR) [2,3]. We have also demonstrated recently a free-radical procedure for structural modification of both forskolin and manoyl oxides [4,5] leading to an unusual distal functionalization of 13-epi- framework. In order to explore the full potential of such late-stage functionalization, one needs reliable sources of 13-epi-manoyl oxide 3, which ideally is made available via selective synthesis. The current work presents the selective one-step synthesis of 13-epi-manoyl oxide 3 basing on a low-temperature superacidic cyclization of sclareol 1 (Scheme 1). An older contribution of some of us reported an equimolar mixture of epimers [6]. Now, the reaction conditions have been finely tuned in order to achieve a 9:1 ratio in favor of the desired 13-epioxide 3. The preparative value of the elaborated procedure was convincingly demonstrated. Scheme 1</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-12492</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-69213</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-11134</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-137</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-672</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-12140</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> </cfPers_ResPubl> <cfFedId> <cfFedIdId>ibn-doi-131137</cfFedIdId> <cfFedId>10.19261/nfnpc.2021</cfFedId> <cfStartDate>2021T24:00:00</cfStartDate> <cfFedId_Class> <cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId> <cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId> </cfFedId_Class> <cfFedId_Srv> <cfSrvId>5123451</cfSrvId> <cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId> </cfFedId_Srv> </cfFedId> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-12492</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-12492-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> <cfFamilyNames>Морареску</cfFamilyNames> <cfFirstNames>Ольга</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-69213</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-69213-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> <cfFamilyNames>Traistari</cfFamilyNames> <cfFirstNames>Marionela</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-11134</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11134-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> <cfFamilyNames>Barba</cfFamilyNames> <cfFirstNames>Alic</cfFirstNames> <cfFamilyNames>Барба</cfFamilyNames> <cfFirstNames>Алик</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-137</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-137-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> <cfFamilyNames>Duka</cfFamilyNames> <cfFirstNames>Gh.</cfFirstNames> <cfFamilyNames>Дука</cfFamilyNames> <cfFirstNames>Георгий</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-672</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-672-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> <cfFamilyNames>Ungur</cfFamilyNames> <cfFirstNames>Nikon</cfFirstNames> <cfFamilyNames>Унгур</cfFamilyNames> <cfFirstNames>Никон</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-12140</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-12140-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021T24:00:00</cfStartDate> <cfFamilyNames>Kulciţki</cfFamilyNames> <cfFirstNames>Veaceslav</cfFirstNames> </cfPersName_Pers> </cfPers> <cfSrv> <cfSrvId>5123451</cfSrvId> <cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName> <cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr> <cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw> </cfSrv> </CERIF>